Added value of 3D-vision during robotic surgery in biotissue pancreatico- and hepaticojejunostomy (LAEBOT 3D2D): a randomized controlled cross-over trial
Recruiting
- Conditions
- ot applicable: Setting is experimental.
- Registration Number
- NL-OMON25901
- Lead Sponsor
- o sponsors.
- Brief Summary
AELAPS3Dvs2D LAELAPS-2
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Surgeons who are capable of robot-assisted suturing. Experience with minimally invasive pancreatoduodenectomy is not required.
Exclusion Criteria
< 18 years
Participants (n = 0) will be excluded if they have no 3D-vision abilities, <200 seconds of arc ((assessed using a Randot Test (Stereo optical, Chicago, IL, USA).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint will be the time required to complete both PJ and HJ.
- Secondary Outcome Measures
Name Time Method Secondary endpoint will be the objective structured assessment of technical skill (OSATS; range 12-60) rating; which will be scored by three observers blinded to 3D/2D.